Arcutis Biotherapeutics Stock Price on November 19, 2024
| ARQT Stock | USD 12.25 0.52 4.07% |
Below is the normalized historical share price chart for Arcutis Biotherapeutics extending back to January 31, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Arcutis Biotherapeutics stands at 12.25, as last reported on the 13th of December 2024, with the highest price reaching 12.89 and the lowest price hitting 12.07 during the day.
If you're considering investing in Arcutis Stock, it is important to understand the factors that can impact its price. Arcutis Biotherapeutics appears to be not too volatile, given 3 months investment horizon. Arcutis Biotherapeutics secures Sharpe Ratio (or Efficiency) of 0.0964, which signifies that the company had a 0.0964% return per unit of standard deviation over the last 3 months. We have found twenty-eight technical indicators for Arcutis Biotherapeutics, which you can use to evaluate the volatility of the firm. Please makes use of Arcutis Biotherapeutics' mean deviation of 2.81, and Risk Adjusted Performance of 0.0658 to double-check if our risk estimates are consistent with your expectations.
At this time, Arcutis Biotherapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 1.1 B in 2024, whereas Common Stock Total Equity is likely to drop 4,950 in 2024. . At this time, Arcutis Biotherapeutics' Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.03 in 2024, whereas Price To Operating Cash Flows Ratio is likely to drop (0.95) in 2024. Arcutis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 31st of January 2020 | 200 Day MA 9.7356 | 50 Day MA 10.1696 | Beta 1.185 |
Arcutis |
Sharpe Ratio = 0.0964
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ARQT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.83 actual daily | 34 66% of assets are more volatile |
Expected Return
| 0.37 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Arcutis Biotherapeutics is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arcutis Biotherapeutics by adding it to a well-diversified portfolio.
Price Book 9.1534 | Enterprise Value Ebitda (2.04) | Price Sales 10.7756 | Shares Float 85.8 M | Wall Street Target Price 19 |
Arcutis Biotherapeutics Main Headline on 19th of November 2024
Arcutis Biotherapeutics SVP sells shares worth 712,620 by investing.com
Arcutis Biotherapeutics SVP sells shares worth 712,620
Arcutis Biotherapeutics Valuation on November 19, 2024
It is possible to determine the worth of Arcutis Biotherapeutics on a given historical date. On November 19, 2024 Arcutis was worth 9.33 at the beginning of the trading date compared to the closed value of 10.09. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Arcutis Biotherapeutics stock. Still, in general, we apply an absolute valuation method to find Arcutis Biotherapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Arcutis Biotherapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Arcutis Biotherapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 9.27 | 9.46 | 8.90 | 9.43 | 1,960,308 | |
11/19/2024 | 9.33 | 10.10 | 9.19 | 10.09 | 1,884,377 |
| 10.18 | 10.42 | 9.93 | 10.18 | 1,025,343 |
| Backtest Arcutis Biotherapeutics | | | Arcutis Biotherapeutics History | | | Arcutis Biotherapeutics Valuation | Previous | Next |
Arcutis Biotherapeutics Trading Date Momentum on November 19, 2024
| On November 20 2024 Arcutis Biotherapeutics was traded for 10.18 at the closing time. The top price for the day was 10.42 and the lowest listed price was 9.93 . The trading volume for the day was 1 M. The trading history from November 20, 2024 was a factor to the next trading day price appreciation. The overall trading delta against the next closing price was 0.89% . The overall trading delta against the current closing price is 16.75% . |
Arcutis Biotherapeutics Fundamentals Correlations and Trends
By evaluating Arcutis Biotherapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Arcutis Biotherapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Arcutis financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Arcutis Biotherapeutics Stock history
Arcutis Biotherapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Arcutis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Arcutis Biotherapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Arcutis Biotherapeutics stock prices may prove useful in developing a viable investing in Arcutis Biotherapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 69.3 M | 44.6 M | |
| Net Loss | -280.3 M | -266.3 M |
Arcutis Biotherapeutics Quarterly Net Working Capital |
|
Arcutis Biotherapeutics Stock Technical Analysis
Arcutis Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Arcutis Biotherapeutics Period Price Range
Low | December 13, 2024
| High |
0.00 | 0.00 |
Arcutis Biotherapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Arcutis Biotherapeutics December 13, 2024 Market Strength
Market strength indicators help investors to evaluate how Arcutis Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arcutis Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Arcutis Biotherapeutics stock market strength indicators, traders can identify Arcutis Biotherapeutics entry and exit signals to maximize returns
Arcutis Biotherapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Arcutis Biotherapeutics' price direction in advance. Along with the technical and fundamental analysis of Arcutis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Arcutis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0658 | |||
| Jensen Alpha | 0.1127 | |||
| Total Risk Alpha | (0.24) | |||
| Sortino Ratio | 0.0507 | |||
| Treynor Ratio | 0.1661 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Arcutis Stock Analysis
When running Arcutis Biotherapeutics' price analysis, check to measure Arcutis Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcutis Biotherapeutics is operating at the current time. Most of Arcutis Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Arcutis Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcutis Biotherapeutics' price. Additionally, you may evaluate how the addition of Arcutis Biotherapeutics to your portfolios can decrease your overall portfolio volatility.